Latest

22:02
【J&T EXPRESS-W(01519.HK) will spend HKD 39.16 million to repurchase 4.47 million shares on Jun 10, 2026】NewTimeSpace News: J&T EXPRESS-W(01519.HK) will spend HKD 39.16 million to repurchase 4.47 million shares on Jun 10, 2026.
Tag： J&T Express-W01519.HK股份回购
22:00
【XIAOMI-W(01810.HK) will spend HKD 97.4 million to repurchase 3.7 million shares on Jun 10, 2026】NewTimeSpace News: XIAOMI-W(01810.HK) will spend HKD 97.4 million to repurchase 3.7 million shares on Jun 10, 2026.
Tag： XIAOMI-W01810.HKShare Repurchase
21:38
【XD Inc. (02400.HK): Launches HK$400 Million Automatic Share Buyback Programme, Granted Waiver for Trading During Restricted Period by HKEX】NewTimeSpace News: XD Inc. (02400.HK) announced that it entered into a share buyback agreement with an independent broker on June 10, 2026, launching an automatic share buyback programme of up to HK$400 million, which will expire on November 11, 2026. The Hong Kong Stock Exchange has granted a waiver permitting the Company to conduct share buybacks during the restricted period prior to the release of financial results.
Tag： XD INC02400.HKShare Repurchase
21:14
【TIANQI LITHIUM(09696.HK): Partial Fire Occurs During Maintenance at Talison's Phase 3 Lithium Concentrate Plant, No Injuries Reported】NewTimeSpace News: Tianqi Lithium Corporation (09696.HK) announced that a partial fire broke out during maintenance at Talison's Phase 3 chemical-grade lithium concentrate plant in Australia. The fire was put out promptly. All on-site staff were evacuated safely with no injuries. Major equipment and production lines remain intact, while the plant's production ramp-up progress may be affected.
Tag： TIANQI LITHIUM09696.HKPlantIncident
19:47
【KINTOR PHARMA-B(09939.HK): KT-939 Shows Favorable Interim Data in Long-term Human Safety Trial, New Raw Material Registration Initiated】NewTimeSpace News: Kintor Pharmaceutical Limited (09939.HK) announced that the interim results of the long-term human safety trial for its core product KT-939 were positive. None of the 119 subjects experienced any adverse skin reactions after 28 consecutive weeks of use, demonstrating a sound safety profile. Meanwhile, the Company has launched the registration application for KT-939 as a new cosmetic raw material, with relevant technical documents submitted to the National Institutes for Food and Drug Control.
Tag： KINTOR PHARMA-B09939.HKCosmeticRawMaterial
19:41
【SF HOLDING(06936.HK) will spend CNY 99.99 million to repurchase 2.87 million shares on Jun 10, 2026】NewTimeSpace News: SF HOLDING(06936.HK) will spend CNY 99.99 million to repurchase 2.87 million shares on Jun 10, 2026.
Tag： SF HOLDING06936.HKShare Repurchase
19:39
【GCL TECH(03800.HK) will spend HKD 81.3 million to repurchase 109.09 million shares on Jun 10, 2026】NewTimeSpace News: GCL TECH(03800.HK) will spend HKD 81.3 million to repurchase 109.09 million shares on Jun 10, 2026.
Tag： GCL TECH03800.HKShare Repurchase
19:38
【MIDEA GROUP(00300.HK) will spend CNY 45.39 million to repurchase 545.5 thousand shares on Jun 10, 2026】NewTimeSpace News: MIDEA GROUP(00300.HK) will spend CNY 45.39 million to repurchase 545.5 thousand shares on Jun 10, 2026.
Tag： MIDEA GROUP00300.HKShare Repurchase
19:37
【WUXI APPTEC(02359.HK) will spend HKD 242.53 million to repurchase 2.03 million shares on Jun 10, 2026】NewTimeSpace News: WUXI APPTEC(02359.HK) will spend HKD 242.53 million to repurchase 2.03 million shares on Jun 10, 2026.
Tag： WuXi AppTec02359.HKShare Repurchase
19:36
【DLC ASIA(08210.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 11.22 million, turned into a loss from a profit YoY】NewTimeSpace News: June 10, 2026, DLC ASIA(08210.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 32.58 million, decreased by 30.42% YoY
Tag： DLC ASIA08210.HKturned into a loss from a profit
19:35
【MNSO(09896.HK) will spend HKD 49.98 million to repurchase 1.93 million shares on Jun 10, 2026】NewTimeSpace News: MNSO(09896.HK) will spend HKD 49.98 million to repurchase 1.93 million shares on Jun 10, 2026.
Tag： MNSO09896.HKShare Repurchase
19:33
【TENCENT(00700.HK) will spend HKD 500.68 million to repurchase 1.08 million shares on Jun 10, 2026】NewTimeSpace News: TENCENT(00700.HK) will spend HKD 500.68 million to repurchase 1.08 million shares on Jun 10, 2026.
Tag： Tencent00700.HKShare Repurchase
19:21
【CSPC PHARMA(01093.HK): Phase III Study of Anistolimab Combined with HB1801 for HER2-positive Advanced Breast Cancer Meets Primary Endpoint】NewTimeSpace News: CSPC Pharmaceutical Group Limited (01093.HK) announced that the Phase III clinical trial (KN026-003) evaluating the combination of Anistolimab (KN026), co-developed by its subsidiary Jinmant Bio and Alphamab Oncology, and the Group's self-developed Docetaxel (Albumin-bound) for Injection (HB1801) as first-line treatment for HER2-positive advanced breast cancer has successfully met the primary endpoint of progression-free survival (PFS). The results show statistically significant and clinically meaningful benefits with a favorable safety profile.
Tag： CSPC PHARMA01093.HKClinical Trial
18:56
【C TRANSMISSION(00658.HK): Further Independent Investigation Launched, Grant Thornton Appointed as Forensic Advisor】NewTimeSpace News: China High Speed Transmission Equipment Group Co., Ltd. (00658.HK) announced that after the current Board and auditor conducted an initial review of the final report by FTI Consulting, they deemed the report failed to fully and accurately reflect the essence of relevant agreements. The Board has authorised the Independent Investigation Committee to oversee a further independent investigation and appointed Grant Thornton Certified Public Accountants (Special General Partnership) as an independent third-party forensic advisor.
Tag： C TRANSMISSION00658.HKindependent investigation
18:48
【HANSOH PHARMA(03692.HK): NDA for HS-10568 Injection Accepted by NMPA for Secondary Hyperparathyroidism in Dialysis Patients】NewTimeSpace News: Hansoh Pharmaceutical Group Company Limited (03692.HK) announced that the New Drug Application (NDA) for its innovative drug HS-10568 Injection (partner code: SHR6508) was accepted by the National Medical Products Administration (NMPA) on June 9, 2026. It is indicated for secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease undergoing hemodialysis. HS-10568 is an allosteric modulator of calcium-sensing receptor (CaSR).
Tag： HANSOH PHARMA03692.HKNew Drug Application
18:37
【BAO PHARMA-B(02659.HK): Subcutaneous Infusion Ceftriaxone Sodium BJ007 FDA IND Approval】NewTimeSpace News: Shanghai Bao Pharmaceuticals Co., Ltd. (02659.HK) announced that the Investigational New Drug (IND) application for its self-developed subcutaneous infusion ceftriaxone sodium BJ007 has been approved by the U.S. Food and Drug Administration (FDA), authorizing clinical trials. According to Frost & Sullivan, no subcutaneous ceftriaxone sodium has been approved globally, and BJ007 is the first and only candidate drug in its class to enter clinical development.
Tag： BAO PHARMA-B02659.HKinvestigational new drug
18:15
【DONGJIANG ENV(00895.HK): Subsidiary Daxiang Logistics Plans to Participate in Steel Transportation Public Tender of Zhongnan Co., Ltd.】NewTimeSpace News: Dongjiang Environmental Company Limited (00895.HK) announced that its non-wholly-owned subsidiary Daxiang Logistics intends to join the public tender for the road transportation and direct delivery project of finished steel products of Zhongnan Co., Ltd. The service term is one year from July 1, 2026 to June 30, 2027, with a proposed bidding budget of RMB 20 million. If successful in the tender, Daxiang Logistics will sign a Road Transportation Contract with Ouye Logistics.
Tag： DONGJIANG ENV00895.HKpublic tender
18:09
【CITIC FAMC(02799.HK): Appointment Qualification of Chief Compliance Officer Liu Zeyun Approved by State Administration of Financial Regulation】NewTimeSpace News: China CITIC Financial Asset Management Co., Ltd. (02799.HK) announced that it has received the official reply (Jin Fu [2026] No. 316) from the State Administration of Financial Regulation approving the qualification of Mr. Liu Zeyun to serve as the Company's Chief Compliance Officer. His term of office took effect on June 3, 2026.
Tag： CITIC FAMC02799.HKapproval of appointment qualification
17:38
【PRODUCTIVE TECH(00650.HK) closed 10% lower on Jun 10, the Hang Seng Semiconductors Sector posted broad declines】NewTimeSpace (newtimespace.com) News, By the close of trading on Jun 10, 2026, PRODUCTIVE TECH(00650.HK) saw a loss of 10% in its share price, closing at HKD 0.405. During the session, it reached an intraday high of HKD 0.48 and touched an intraday low of HKD 0.38.
Tag： PRODUCTIVE TECH00650.HKNewTimeSpace
17:28
【Daily Report on Hong Kong-Listed LLM Concept Stocks (June 10, 2026)】On June 10, the three major Hong Kong indices drifted lower, with chip and LLM concept stocks under selling pressure as ZHIPU AI slid over 7%, while AI application plays like Kuaishou and Tencent bucked the trend. Internationally, Anthropic released its Fable 5 model with tightened security constraints alongside an unaligned version to ease regulatory oversight ahead of its IPO. Domestically, Meituan officially launched its AI-native browser Tabbit 1.0, enabling automated cross-webpage workflows across multiple LLMs, while Zhipu AI allied with HFUT to establish a multi-tier "LLM Innovation Experimental Class" to secure elite talent pipelines for the industry.
Tag： LLMKnowledge AtlasMININGLAMP-W
Previous1..1920 212223..233     233 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments